ASML Faces China Tech Push, Yet Investors Shouldn't Worry
ASML shares swung after reports of China’s push to develop a domestic EUV rival. Yet analysts say the technical and s...
Which No Fee Cash Back Card Is Best For You
Finding the right no fee cash back card can enhance your savings. Discover which card suits your financial habits best.
26,735 articlesStablecoin Bill Enters Final Stage, Yield Rules in Focus
The stablecoin bill enters final stage as negotiators confront whether non-bank issuers can offer yield on reserves. ...
Cowen Raises Match Group Target as Tinder Turnaround Gains
TD Cowen boosts its Match Group target on better Tinder metrics, while UBS stays cautious. The market tests whether T...
DeepSeek: China’s AI Boom Increasingly Fueled by State Money
DeepSeek just secured its first outside investment from a state-backed fund, marking a turning point in China’s AI fu...
Exclusive: Orbital Industries Secures $50M Series B
Orbital Industries closes a $50 million Series B to accelerate AI-powered materials discovery and move toward selling...
Disruption Arrived Years Early—Now Investors React Cautiously
A wave of AI-driven disruption arrived years early—now forcing employers and households to rethink careers, savings, ...
Charles Hoskinson Says Cardano Embraces AI Agents Now
Cardano’s founder positions AI agents as essential infra for Midnight City, while ADA hovers near $0.16 as traders we...
Minting Billion-Dollar Companies Faster: AI Surge
AI is accelerating the pace at which startups reach unicorn status, with policy shifts and market volatility adding c...
Filing Shows Viral Million in XRP ETF Claim Debunked
Brookstone Capital's 13F reveals a modest stake in the XRP ETF, but viral posts claim a $71 million position due to a...
Pentagon Chief Blocks Officers From Elite Universities
The Pentagon unveils a sweeping overhaul of officer education, banning eight elite institutions and authorizing nine ...
CoinFello Launches OpenClaw Skill for AI Agents in 2026
CoinFello debuts OpenClaw Skill, enabling Moltbots to perform on-chain actions through narrowly scoped delegations wh...
Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status